ANF-RHO

· Prolong Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANF-RHO, covering 2019-02-12 to 2019-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia [Phase 2]

See pricing